PortfoliosLab logoPortfoliosLab logo
GN0M.DE vs. XUHC.DE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

GN0M.DE vs. XUHC.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) and Xtrackers MSCI USA Health Care UCITS ETF 1D (XUHC.DE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GN0M.DE achieves a 12.99% return, which is significantly higher than XUHC.DE's -1.34% return.


GN0M.DE

1D
5.61%
1M
11.50%
YTD
12.99%
6M
9.82%
1Y
55.73%
3Y*
-1.90%
5Y*
10Y*

XUHC.DE

1D
2.83%
1M
5.38%
YTD
-1.34%
6M
-1.19%
1Y
12.86%
3Y*
3.62%
5Y*
6.62%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

GN0M.DE vs. XUHC.DE - Yearly Performance Comparison


2026 (YTD)20252024202320222021
GN0M.DE
Global X Genomics & Biotechnology UCITS ETF
12.99%5.67%-12.40%-9.04%-32.50%-7.90%
XUHC.DE
Xtrackers MSCI USA Health Care UCITS ETF 1D
-1.34%1.47%8.81%-0.83%2.49%6.97%

Correlation

The correlation between GN0M.DE and XUHC.DE is 0.49, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.49

Correlation (3Y)
Calculated over the trailing 3-year period

0.44

Correlation (All Time)
Calculated using the full available price history since Nov 12, 2021

0.46

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GN0M.DE vs. XUHC.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GN0M.DE
GN0M.DE Risk / Return Rank: 5858
Overall Rank
GN0M.DE Sharpe Ratio Rank: 6060
Sharpe Ratio Rank
GN0M.DE Sortino Ratio Rank: 6161
Sortino Ratio Rank
GN0M.DE Omega Ratio Rank: 5454
Omega Ratio Rank
GN0M.DE Calmar Ratio Rank: 6868
Calmar Ratio Rank
GN0M.DE Martin Ratio Rank: 5050
Martin Ratio Rank

XUHC.DE
XUHC.DE Risk / Return Rank: 2424
Overall Rank
XUHC.DE Sharpe Ratio Rank: 2525
Sharpe Ratio Rank
XUHC.DE Sortino Ratio Rank: 2626
Sortino Ratio Rank
XUHC.DE Omega Ratio Rank: 2323
Omega Ratio Rank
XUHC.DE Calmar Ratio Rank: 2323
Calmar Ratio Rank
XUHC.DE Martin Ratio Rank: 2222
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GN0M.DE vs. XUHC.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) and Xtrackers MSCI USA Health Care UCITS ETF 1D (XUHC.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


GN0M.DEXUHC.DEDifference
Sharpe ratioReturn per unit of total volatility

+1.16

Sortino ratioReturn per unit of downside risk

+1.47

Omega ratioGain probability vs. loss probability

1.33

1.15

+0.18

Calmar ratioReturn relative to maximum drawdown

3.32

1.10

+2.23

Martin ratioReturn relative to average drawdown

8.35

2.69

+5.66

GN0M.DE vs. XUHC.DE - Sharpe Ratio Comparison

The current GN0M.DE Sharpe Ratio is 2.00, which is higher than the XUHC.DE Sharpe Ratio of 0.85. The chart below compares the historical Sharpe Ratios of GN0M.DE and XUHC.DE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


GN0M.DEXUHC.DEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.00

0.85

+1.16

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.45

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.34

0.56

-0.91

Drawdowns

GN0M.DE vs. XUHC.DE - Drawdown Comparison

The maximum GN0M.DE drawdown since its inception was -67.19%, which is greater than XUHC.DE's maximum drawdown of -26.87%. Use the drawdown chart below to compare losses from any high point for GN0M.DE and XUHC.DE.


Loading charts...

Drawdown Indicators


GN0M.DEXUHC.DEDifference

Max Drawdown

Largest peak-to-trough decline

-67.19%

-26.87%

-40.32%

Max Drawdown (1Y)

Largest decline over 1 year

-16.68%

-11.18%

-5.50%

Max Drawdown (3Y)

Largest decline over 3 years

-48.19%

-22.19%

-26.00%

Max Drawdown (5Y)

Largest decline over 5 years

-22.19%

Current Drawdown

Current decline from peak

-41.03%

-7.48%

-33.55%

Average Drawdown

Average peak-to-trough decline

-43.13%

-5.08%

-38.05%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.65%

4.57%

+2.08%

Volatility

GN0M.DE vs. XUHC.DE - Volatility Comparison

Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) has a higher volatility of 8.15% compared to Xtrackers MSCI USA Health Care UCITS ETF 1D (XUHC.DE) at 5.19%. This indicates that GN0M.DE's price experiences larger fluctuations and is considered to be riskier than XUHC.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GN0M.DEXUHC.DEDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.15%

5.19%

+2.96%

Volatility (6M)

Calculated over the trailing 6-month period

19.69%

10.17%

+9.52%

Volatility (1Y)

Calculated over the trailing 1-year period

27.68%

14.51%

+13.17%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

31.49%

14.42%

+17.07%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

31.49%

16.13%

+15.36%

GN0M.DE vs. XUHC.DE - Expense Ratio Comparison

GN0M.DE has a 0.50% expense ratio, which is higher than XUHC.DE's 0.12% expense ratio.


Dividends

GN0M.DE vs. XUHC.DE - Dividend Comparison

GN0M.DE has not paid dividends to shareholders, while XUHC.DE's dividend yield for the trailing twelve months is around 1.28%.


PositionTTM20252024202320222021202020192018
GN0M.DE
Global X Genomics & Biotechnology UCITS ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
XUHC.DE
Xtrackers MSCI USA Health Care UCITS ETF 1D
1.28%1.29%1.21%1.86%1.63%0.82%1.13%0.96%0.55%

Frequently Asked Questions


GN0M.DE and XUHC.DE have a correlation of 0.49, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, XUHC.DE is cheaper at 0.12% per year. The better choice depends on whether you care most about return, fees, risk, or income.

XUHC.DE is cheaper with a 0.12% expense ratio, compared with 0.50% for GN0M.DE.

GN0M.DE tracks Solactive Genomics, while XUHC.DE tracks MSCI USA Health Care. They also come from different issuers: Global X and Xtrackers. Their fees differ too: 0.50% for GN0M.DE and 0.12% for XUHC.DE.

Portfolio Optimizer

Find the right allocation for GN0M.DE and XUHC.DE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer